New Review Paper Spotlights Bovine Colostrum for Gastrointestinal Health

PanTheryx, the world’s largest colostrum-based nutrition and biotechnology company, today announced the publication of a new scientific paper titled, “Colostrum therapy for human gastrointestinal health and disease” in the peer-reviewed journal Nutrients. As a part of the Nutrients’ Special Issue series on colostrum, the current publication identifies bovine colostrum as a complex biological matrix comprised of growth factors, nutrients, hormones and paracrine factors, which have a range of properties that contribute to mucosal healing resulting for a variety of gastrointestinal conditions.